semaglutide compounding news november 2025 Drug compounders sue FDA over declaration ending Wegovy shortage Despite FDA ruling, compounded GLP-1s

An exclusive in-app community where you can get support for your journey, and an expert-designed behavior change program to help you make lasting changes

These secondary benefits often provide the most meaningful quality of life improvements

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management

Love this stuff

Bbs5 / mice had a pancreas size similar to that in WT mice (Figure 1P), but displayed pancreatic islet hyperplasia (Figure 1Q), with a greater percentage of islet relative to pancreas area (Figure 1R), larger average islet size (Figure 1, S and T), and an increased number of insulin cells per islet (Figure 1U)

In support of this hypothesis, locking the ECDTMD interactions with disulfide bonds compromises the functional efficiency of GLP-1